Artículo
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
Oviedo Rouco, Santiago
; Rodriguez, Pamela Elizabeth
; Miglietta, Esteban Alberto
; Rall, Pablo; González López Ledesma, María Mora
; Varese, Augusto
; Pascuale, Carla Antonela
; Ojeda, Diego Sebastian
; Mazzitelli, Bianca; Sanchez, Lautaro Nicolas
; Ceballos, Ana
; Perez, Eduardo; Geffner, Jorge Raúl
; Miragaya, Yanina Daniela; Rossi, Andrés Hugo
; Gamarnik, Andrea Vanesa
Fecha de publicación:
08/2022
Editorial:
Elsevier Science Inc.
Revista:
Lancet Infectious Diseases
ISSN:
1473-3099
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Whole-virion inactivated SARS-CoV-2 vaccines are one of the most widely used vaccines worldwide. However, compared with the mRNA-based and adenovirus-based platforms,1 little information is available about the immune response that is induced by inactivated virus vaccines2 and the convenience of applying heterologous boosters to reach an improved response against variants of concern, including omicron (B.1.1.529). Particularly scarce are data for older people (ie, age >60 years).
Palabras clave:
SARS-COV-2
,
VACCINATION
,
BBIBP-CORV
,
HETEROLOGOUS
,
COVID-19
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IIBBA)
Articulos de INST.DE INVEST.BIOQUIMICAS DE BS.AS(I)
Articulos de INST.DE INVEST.BIOQUIMICAS DE BS.AS(I)
Articulos(INBIRS)
Articulos de INSTITUTO DE INVESTIGACIONES BIOMEDICAS EN RETROVIRUS Y SIDA
Articulos de INSTITUTO DE INVESTIGACIONES BIOMEDICAS EN RETROVIRUS Y SIDA
Citación
Oviedo Rouco, Santiago; Rodriguez, Pamela Elizabeth; Miglietta, Esteban Alberto; Rall, Pablo; González López Ledesma, María Mora; et al.; Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people; Elsevier Science Inc.; Lancet Infectious Diseases; 22; 8; 8-2022; 1118-1119
Compartir
Altmétricas